<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2017.4.77-82</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-190</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Содержание адипокинов в сыворотке крови у лиц различного сердечно-сосудистого риска</article-title><trans-title-group xml:lang="en"><trans-title>The serum levels of adipokines in individuals with different cardiovascular risk</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родионова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rodionova</surname><given-names>L. V.</given-names></name></name-alternatives><email xlink:type="simple">larisa_90.08@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плехова</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Plechova</surname><given-names>N. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданов</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanov</surname><given-names>D. Y.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарчук</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaharchuk</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тихоокеанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pacific State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2017</year></pub-date><volume>0</volume><issue>4</issue><fpage>77</fpage><lpage>82</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Родионова Л.В., Плехова Н.Г., Богданов Д.Ю., Захарчук Н.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Родионова Л.В., Плехова Н.Г., Богданов Д.Ю., Захарчук Н.В.</copyright-holder><copyright-holder xml:lang="en">Rodionova L.V., Plechova N.G., Bogdanov D.Y., Zaharchuk N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/190">https://www.tmj-vgmu.ru/jour/article/view/190</self-uri><abstract><p>С целью оценки показателей адипокинов сыворотки крови во взаимосвязи с факторами риска сердечно-сосудистых заболеваний обследованы 395 человек, из них 215 пациентов с артериальной гипертонией (АГ). При комбинации таких факторов риска, как избыточный вес, курение, дислипидемии у пациентов с АГ отмечалось значительное изменение адипокинового профиля: повышение уровня резистина и снижение уровня адипонектина. Обнаружены взаимосвязи между интенсивностью курения и концентрацией резистина и адипонектина.</p></abstract><trans-abstract xml:lang="en"><p>Objective. Arterial hypertension (AH) is one of the most common diseases in the world and the most significant morbidity and mortality cause in working age individuals. According to the results of a multicenter epidemiological study ESSE-RF with the participation 15571 patients from ten country regions, in recent years the prevalence of hypertension in the population increased from 39.7 to 43.4%. Methods. The research included 395 individuals aged 25 to 60 years, of whom 215 patients with hypertension. All participants measured the height, weight, waist circumference, body mass index, counting the index of the smoker, determined the lipid profile and adipokine levels in serum by enzyme immunoassay. Results. In patients with hypertension compared with the control group showed a significant decrease in serum adiponectin, the content of resistin had opposite results. The lowest adiponectin concentration obtained in combinations of risk factors hypertension and smoking. Relationship between the smoking intensity and resistin concentration and adiponectin had been identified. Conclusions. The data indicated a higher factors combination contribution in the development of metabolic problems, diabetes and coronary heart disease. It is revealed that for the better definition the risk of cardiovascular accidents in individuals with traditional risk factors combination (hypertension and smoking) should to consider the adipokines definition in the serum, in particular adiponectin and resistin.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>лептин</kwd><kwd>резистин</kwd><kwd>адипонектин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>leptin</kwd><kwd>resistin</kwd><kwd>adiponectin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ковалева Ю.В. Гормоны жировой ткани и их роль в формировании гормонального статуса и патогенеза метаболических нарушений у женщин // Артериальная гипертензия. 2015. Т. 21, № 4. С. 356-370</mixed-citation><mixed-citation xml:lang="en">Ковалева Ю.В. Гормоны жировой ткани и их роль в формировании гормонального статуса и патогенеза метаболических нарушений у женщин // Артериальная гипертензия. 2015. Т. 21, № 4. С. 356-370</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е. Артериальная гипертензия и дислипидемия: основные направления стратегии лечения больных высокого сердечно-сосудистого риска // Эффективная фармакотерапия: кардиология и ангиология. 2015. № 3. С. 42-49</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е. Артериальная гипертензия и дислипидемия: основные направления стратегии лечения больных высокого сердечно-сосудистого риска // Эффективная фармакотерапия: кардиология и ангиология. 2015. № 3. С. 42-49</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Allison M.A., Ix J.H., Morgan C. [et al.]. Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis // J. Hum. Hypertens. 2013. Vol. 27, No. 10. P. 617-622.</mixed-citation><mixed-citation xml:lang="en">Allison M.A., Ix J.H., Morgan C. [et al.]. Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis // J. Hum. Hypertens. 2013. Vol. 27, No. 10. P. 617-622.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Efstathiou S.P., Pefanis A.V., Mountokalakis Th.D. [et al.]. Plasma Adiponectin levels and five-year survival after first-ever Ischemic // Stroke. 2005. Vol. 36. P. 1915-1919.</mixed-citation><mixed-citation xml:lang="en">Efstathiou S.P., Pefanis A.V., Mountokalakis Th.D. [et al.]. Plasma Adiponectin levels and five-year survival after first-ever Ischemic // Stroke. 2005. Vol. 36. P. 1915-1919.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">European Guidelines on cardiovascular disease prevention in clinical practice, 2016 // European Heart Journal. 2016. Vol. 37. P. 2315-2381.</mixed-citation><mixed-citation xml:lang="en">European Guidelines on cardiovascular disease prevention in clinical practice, 2016 // European Heart Journal. 2016. Vol. 37. P. 2315-2381.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huocheng L., Li Z., Zheng D. [et al.]. Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness // Lipids Health Dis. 2014. Vol. 13. P. 120-125.</mixed-citation><mixed-citation xml:lang="en">Huocheng L., Li Z., Zheng D. [et al.]. Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness // Lipids Health Dis. 2014. Vol. 13. P. 120-125.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kazumi T., Kawaguchi A., Sakai K. [et al.]. Young men with highnormal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure // Diabetes Care. 2002. Vol. 25, No. 6. P. 971-976.</mixed-citation><mixed-citation xml:lang="en">Kazumi T., Kawaguchi A., Sakai K. [et al.]. Young men with highnormal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure // Diabetes Care. 2002. Vol. 25, No. 6. P. 971-976.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kubota N., Yano W., Kubota T. [et al.]. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake // Cell Metab. 2007. Vol. 6, No. 1. P. 55-68.</mixed-citation><mixed-citation xml:lang="en">Kubota N., Yano W., Kubota T. [et al.]. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake // Cell Metab. 2007. Vol. 6, No. 1. P. 55-68.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Melone M., Wilsie L., Palyha O. [et al.]. Discovery of a new role of human resistin hepotocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subutilisin/Kexin type 9 // J. Am. Coll. Cardiol. 2012. Vol. 59, No. 19. P. 1697-1705.</mixed-citation><mixed-citation xml:lang="en">Melone M., Wilsie L., Palyha O. [et al.]. Discovery of a new role of human resistin hepotocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subutilisin/Kexin type 9 // J. Am. Coll. Cardiol. 2012. Vol. 59, No. 19. P. 1697-1705.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mtiraoui N., Ezzidi I., Turki A. [et al.]. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs // Diabetes Res. Clin. Pract. 2012. Vol. 97, No. 2. P. 290-297.</mixed-citation><mixed-citation xml:lang="en">Mtiraoui N., Ezzidi I., Turki A. [et al.]. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs // Diabetes Res. Clin. Pract. 2012. Vol. 97, No. 2. P. 290-297.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Roth G.A., Johnson C., Abajobir A. [et al.]. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1995 to 2015 // JACC. 2017. Vol. 70, No. 1. P. 1-25.</mixed-citation><mixed-citation xml:lang="en">Roth G.A., Johnson C., Abajobir A. [et al.]. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1995 to 2015 // JACC. 2017. Vol. 70, No. 1. P. 1-25.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sakovskaia A., Nevzorova V., Brodskaya T., Chkalovec I. Condition aortic stiffness and content of adipokines in the serum of patients with essential hypertension in young and middle-aged // Journal of Hypertension. 2015. Vol. 33, e-Suppl. 1. P. 182.</mixed-citation><mixed-citation xml:lang="en">Sakovskaia A., Nevzorova V., Brodskaya T., Chkalovec I. Condition aortic stiffness and content of adipokines in the serum of patients with essential hypertension in young and middle-aged // Journal of Hypertension. 2015. Vol. 33, e-Suppl. 1. P. 182.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Takata Y., Osawa H., Kurata M. [et al.]. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes // J. Hypertens. 2008. Vol. 51, No. 2. P. 534-539.</mixed-citation><mixed-citation xml:lang="en">Takata Y., Osawa H., Kurata M. [et al.]. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes // J. Hypertens. 2008. Vol. 51, No. 2. P. 534-539.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Takeishi Y., Niizeki T., Arimoto T. [et al.]. Serum resistin is associated with high risk in patients with congestive heart failure: a novel link between metabolic signals and heart failure // Circ. J. 2007. Vol. 71. P. 460-464.</mixed-citation><mixed-citation xml:lang="en">Takeishi Y., Niizeki T., Arimoto T. [et al.]. Serum resistin is associated with high risk in patients with congestive heart failure: a novel link between metabolic signals and heart failure // Circ. J. 2007. Vol. 71. P. 460-464.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon J.-H., Kim S.-K., Choi H.-J. ^t al.]. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders // PLoS One. 2013. Vol. 8, No. 10. P. e75535.</mixed-citation><mixed-citation xml:lang="en">Yoon J.-H., Kim S.-K., Choi H.-J. ^t al.]. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders // PLoS One. 2013. Vol. 8, No. 10. P. e75535.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
